Harmony Biosciences Holdings Inc (HRMY)
33.58
+0.06
(+0.18%)
USD |
NASDAQ |
Mar 28, 16:00
33.55
-0.03
(-0.09%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap: 1.906B for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 28, 2024 | 1.906B |
March 27, 2024 | 1.903B |
March 26, 2024 | 1.818B |
March 25, 2024 | 1.851B |
March 22, 2024 | 1.891B |
March 21, 2024 | 1.905B |
March 20, 2024 | 1.910B |
March 19, 2024 | 1.835B |
March 18, 2024 | 1.793B |
March 15, 2024 | 1.815B |
March 14, 2024 | 1.780B |
March 13, 2024 | 1.699B |
March 12, 2024 | 1.727B |
March 11, 2024 | 1.747B |
March 08, 2024 | 1.765B |
March 07, 2024 | 1.762B |
March 06, 2024 | 1.742B |
March 05, 2024 | 1.746B |
March 04, 2024 | 1.752B |
March 01, 2024 | 1.823B |
February 29, 2024 | 1.822B |
February 28, 2024 | 1.888B |
February 27, 2024 | 1.901B |
February 26, 2024 | 1.843B |
February 23, 2024 | 1.845B |
Date | Value |
---|---|
February 22, 2024 | 1.785B |
February 21, 2024 | 1.873B |
February 20, 2024 | 1.875B |
February 16, 2024 | 1.919B |
February 15, 2024 | 1.990B |
February 14, 2024 | 1.924B |
February 13, 2024 | 1.866B |
February 12, 2024 | 1.962B |
February 09, 2024 | 1.891B |
February 08, 2024 | 1.913B |
February 07, 2024 | 1.810B |
February 06, 2024 | 1.789B |
February 05, 2024 | 1.721B |
February 02, 2024 | 1.769B |
February 01, 2024 | 1.776B |
January 31, 2024 | 1.790B |
January 30, 2024 | 1.805B |
January 29, 2024 | 1.832B |
January 26, 2024 | 1.764B |
January 25, 2024 | 1.762B |
January 24, 2024 | 1.742B |
January 23, 2024 | 1.801B |
January 22, 2024 | 1.847B |
January 19, 2024 | 1.797B |
January 18, 2024 | 1.812B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.125B
Minimum
Oct 27 2023
3.613B
Maximum
Dec 05 2022
2.268B
Average
2.161B
Median
Market Cap Benchmarks
Intra-Cellular Therapies Inc | 6.699B |
Amylyx Pharmaceuticals Inc | 193.18M |
Arrowhead Pharmaceuticals Inc | 3.538B |
Exelixis Inc | 7.195B |
Inovio Pharmaceuticals Inc | 323.68M |
Market Cap Related Metrics
PE Ratio | 15.84 |
PS Ratio | 3.483 |
Price to Book Value | 4.082 |
Price to Free Cash Flow | 9.253 |
Price | 33.58 |
Earnings Yield | 6.31% |
Operating PE Ratio | 10.56 |
Normalized PE Ratio | 15.00 |